Abstract
PurposeTo determine the correlation between blood flow metrics measured by intravenous fluorescein angiography (IVFA) and blood flow velocity index (BFVi) obtained by laser speckle contrast imaging (LSCI) in infants with retinopathy of prematurity (ROP). DesignProspective comparative pilot study. SubjectsSeven eyes from seven subjects with ROP. MethodsUnilateral LSCI and IVFA data was obtained from each subject in the neonatal intensive care unit (NICU). Five LSCI-based metrics and five IVFA-based metrics were extracted from images to quantify blood flow patterns in the same region of interest. Correlation between LSCI-based and IVFA-based blood flow metrics was compared between two subgroups of ROP severity: moderate ROP (defined as stage ≤2 without Plus disease) and severe ROP (defined as stage ≥3 or Plus disease). Main Outcome MeasuresPearson and Kendall’s Rank correlation coefficients between IVFA and LSCI metrics; Student’s t test p values comparing LSCI metrics between “severe” and “moderate” ROP groups. ResultsPearson’s correlations between IVFA and LSCI included arterial-venous transit time (AVTT) and peak BFVi (r = -0.917, p = 0.004), AVTT and dip BFVi (r = -0.920, p = 0.003), AVTT and mean BFVi (r = -0.927, p = 0.003), and AVTT and volumetric rise index (r = -0.779, p = 0.039). Kendall’s Rank correlation between AVTT and dBFVi was r = -0.619 (p = 0.051). Peak BFVi was higher in severe ROP than in moderate ROP (8.4 ± 0.6 and 4.4 ± 1.8 respectively, p = 0.0045 using 2-sample t-test with pooled variance, and p = 0.0952 using Wilcoxon rank-sum test). ConclusionCorrelation was found between blood flow metrics obtained by IVFA and noninvasive LSCI techniques. We demonstrate the feasibility of obtaining quantitative metrics using LSCI in infants with ROP in this pilot study, but further investigation is needed to evaluate its potential use in clinical assessment of ROP severity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.